Sino Biopharmaceutical | 1177 - Current Assets


Sino Biopharmaceutical reported CNY33.82B in Current Assets for its fiscal semester ending in June of 2025.





Current Assets Change Date
Akebia Therapeutics USD 220.78M 8.77M Sep/2026
Alaunos Therapeutics USD 666K 304K Jun/2026
Avita Medical AUD 28.39M 7.1M Jun/2026
Cspc Pharmaceutical CNY 22.25B 359.48M Dec/2025
Dianthus Therapeutics USD 856.04M 41.5M Sep/2026
Ionis Pharmaceuticals USD 2.36B 129.77M Sep/2026
IQVIA Holdings USD 6.45B 225M Sep/2026
Jiangsu Hengrui CNY 54.55B 4.95B Sep/2026
Moderna USD 7.34B 1.53B Sep/2026
Organon & Co USD 5.37B 258M Sep/2026
Revvity USD 1.86B 436.33M Sep/2026
Sino Biopharmaceutical CNY 33.82B 9.13B Jun/2025
Tectonic Therapeutic USD 231.1M 8.79M Jun/2026
Viatris USD 10.3B 242.1M Sep/2026
Xeris Pharmaceuticals USD 289.26M 14.51M Sep/2026